Alan Forman
Director/Board Member at JBG SMITH PROPERTIES
Net worth: 80 928 $ as of 2024-04-29
Profile
Alan S.
Forman's current jobs include being an Investments Director at Yale Investments Office since 1997, a Director at Lirum Therapeutics, Inc. since 2023, a Member at National Association of Corporate Directors (Virginia), and an Independent Trustee at JBG SMITH Properties and JBG SMITH Properties LP.
His former jobs include being a Director at Yale University Endowment from 1990 to 2022, a Director at Kimpton Group Holding LLC, a Director at Stemline Therapeutics, Inc. from 2015 to 2020, and a Trustee at Acadia Realty Trust.
Mr. Forman's education includes an undergraduate degree from Dartmouth College in 1987 and an MBA from The Leonard N Stern School of Business.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
JBG SMITH PROPERTIES
0.01% | 2024-02-25 | 5,363 ( 0.01% ) | 80 928 $ | 2024-04-29 |
JBG SMITH PROPERTIES
-.--% | 2024-04-24 | 0 ( -.--% ) | - $ | 2024-04-29 |
Alan Forman active positions
Companies | Position | Start |
---|---|---|
JBG SMITH PROPERTIES | Director/Board Member | 2016-12-31 |
National Association of Corporate Directors (Virginia)
National Association of Corporate Directors (Virginia) Miscellaneous Commercial ServicesCommercial Services National Association of Corporate Directors provides online and print information services to directors of public companies. It offers in-boardroom education, evaluation, governance reviews, board composition and succession planning, board recruitment, ongoing advisory, insights, and analytics services. The company was founded in 1977 and is headquartered in Arlington, VA. | Corporate Officer/Principal | - |
JBG SMITH Properties LP
JBG SMITH Properties LP Real Estate DevelopmentFinance Part of JBG SMITH Properties, JBG SMITH Properties LP is a company based in Bethesda, MD. JBG SMITH Properties LP was founded in 1957. The CEO is W. Matthew Kelly. | Director/Board Member | - |
Yale Investments Office | Chief Investment Officer | 1997-09-30 |
Lirum Therapeutics, Inc.
Lirum Therapeutics, Inc. BiotechnologyHealth Technology Lirum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the treatment of deliberating diseases. The firm is also involved in the acquisition, development, and commercialization of drug candidates. Its products include LX-101, a targeted therapy directed to the insulin-like growth factor 1 (IGF-1R). The company was founded in November 2021 and is headquartered in New York, NY. | Director/Board Member | 2023-04-30 |
Former positions of Alan Forman
Companies | Position | End |
---|---|---|
Yale University Endowment
Yale University Endowment Investment Trusts/Mutual FundsMiscellaneous Since 1975, the Yale Corporation Investment Committee has been responsible for oversight of the Yale University Endowment. They are located in New Haven, Connecticut | Chief Investment Officer | - |
STEMLINE THERAPEUTICS, INC. | Director/Board Member | - |
Kimpton Group Holding LLC
Kimpton Group Holding LLC Hotels/Resorts/Cruise linesConsumer Services Kimpton Group Holding LLC operates hotels and restaurants. It is the parent company of Kimpton Hotels & Restaurants which is a collection of boutique hotels coupled with chef-driven restaurants. The company was founded in 1981 and is headquartered in San Francisco, CA | Director/Board Member | - |
ACADIA REALTY TRUST | Director/Board Member | - |
Training of Alan Forman
Dartmouth College | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ACADIA REALTY TRUST | Finance |
JBG SMITH PROPERTIES | Finance |
Private companies | 7 |
---|---|
Yale University Endowment
Yale University Endowment Investment Trusts/Mutual FundsMiscellaneous Since 1975, the Yale Corporation Investment Committee has been responsible for oversight of the Yale University Endowment. They are located in New Haven, Connecticut | Miscellaneous |
Kimpton Group Holding LLC
Kimpton Group Holding LLC Hotels/Resorts/Cruise linesConsumer Services Kimpton Group Holding LLC operates hotels and restaurants. It is the parent company of Kimpton Hotels & Restaurants which is a collection of boutique hotels coupled with chef-driven restaurants. The company was founded in 1981 and is headquartered in San Francisco, CA | Consumer Services |
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY. | Health Technology |
National Association of Corporate Directors (Virginia)
National Association of Corporate Directors (Virginia) Miscellaneous Commercial ServicesCommercial Services National Association of Corporate Directors provides online and print information services to directors of public companies. It offers in-boardroom education, evaluation, governance reviews, board composition and succession planning, board recruitment, ongoing advisory, insights, and analytics services. The company was founded in 1977 and is headquartered in Arlington, VA. | Commercial Services |
JBG SMITH Properties LP
JBG SMITH Properties LP Real Estate DevelopmentFinance Part of JBG SMITH Properties, JBG SMITH Properties LP is a company based in Bethesda, MD. JBG SMITH Properties LP was founded in 1957. The CEO is W. Matthew Kelly. | Finance |
Yale Investments Office | |
Lirum Therapeutics, Inc.
Lirum Therapeutics, Inc. BiotechnologyHealth Technology Lirum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the treatment of deliberating diseases. The firm is also involved in the acquisition, development, and commercialization of drug candidates. Its products include LX-101, a targeted therapy directed to the insulin-like growth factor 1 (IGF-1R). The company was founded in November 2021 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Alan Forman